Page last updated: 2024-10-19

niacinamide and Hepatitis

niacinamide has been researched along with Hepatitis in 20 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Hepatitis: INFLAMMATION of the LIVER.

Research Excerpts

ExcerptRelevanceReference
" The aim of this work was to characterize the profile of release of endogenous MNA during the initiation and progression of murine hepatitis induced by Concanavalin A (ConA)."7.81Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis. ( Chlopicki, S; Czarnowska, E; Jakubowski, A; Jasztal, A; Kaminski, K; Sitek, B; Slominska, EM; Smolenski, RT; Sternak, M; Szafarz, M; Walczak, M; Wojcik, T, 2015)
"Sorafenib is a potent drug for advanced HCC with multikinase inhibition activity."5.43Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model. ( Axelrod, JH; Divon, MS; Galun, E; Lanton, T; Peretz, T; Salmon, A; Sonnenblick, A; Zahavi, T, 2016)
" In this study, we demonstrated that IL-10-producing macrophages contribute to immune tolerance in the inflamed liver under intestinal barrier disruption in a murine tandem model of dextran sulfate sodium (DSS) colitis and concanavalin A (Con A) hepatitis."3.88Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages. ( Amiya, T; Chu, PS; Ebinuma, H; Fukuda, S; Kanai, T; Katayama, T; Mikami, Y; Miyake, R; Nakamoto, N; Shiba, S; Suzuki, T; Taniki, N; Teratani, T; Tsukimi, T; Yamaguchi, A, 2018)
" The aim of this work was to characterize the profile of release of endogenous MNA during the initiation and progression of murine hepatitis induced by Concanavalin A (ConA)."3.81Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis. ( Chlopicki, S; Czarnowska, E; Jakubowski, A; Jasztal, A; Kaminski, K; Sitek, B; Slominska, EM; Smolenski, RT; Sternak, M; Szafarz, M; Walczak, M; Wojcik, T, 2015)
" Less than 10% of patients showed evidence of vitamin B12, nicotinic acid, thiamin, or riboflavin deficiency, and 17% had evidence of folic acid deficiency."3.65Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. ( Kelleher, J; Losowsky, MS; Morgan, AG; Walker, BE, 1976)
"Sorafenib is a potent drug for advanced HCC with multikinase inhibition activity."1.43Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model. ( Axelrod, JH; Divon, MS; Galun, E; Lanton, T; Peretz, T; Salmon, A; Sonnenblick, A; Zahavi, T, 2016)

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-199015 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.00)29.6817
2010's4 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taniki, N1
Nakamoto, N1
Chu, PS1
Mikami, Y1
Amiya, T1
Teratani, T1
Suzuki, T1
Tsukimi, T1
Fukuda, S1
Yamaguchi, A1
Shiba, S1
Miyake, R1
Katayama, T1
Ebinuma, H1
Kanai, T1
Annadurai, T1
Thomas, PA1
Geraldine, P1
Sternak, M1
Jakubowski, A1
Czarnowska, E1
Slominska, EM1
Smolenski, RT1
Szafarz, M1
Walczak, M1
Sitek, B1
Wojcik, T1
Jasztal, A1
Kaminski, K1
Chlopicki, S1
Zahavi, T1
Lanton, T1
Divon, MS1
Salmon, A1
Peretz, T1
Galun, E1
Axelrod, JH1
Sonnenblick, A1
Mejias, M1
Garcia-Pras, E1
Tiani, C1
Miquel, R1
Bosch, J1
Fernandez, M1
OJI, N1
CALABRESE, L1
BERTI, P1
CAMATTE, R1
BENVESTITO, V1
MARTELLOTTA, G1
VIGGIANO, N1
USAITIS, J1
MAINOLI, S1
GRASSO, E1
KRASNOVA, NS1
TOTTERMAN, LE1
Morgan, AG1
Kelleher, J1
Walker, BE1
Losowsky, MS1
Vorberg, G1
Pagliaro, L1
Catalfamo, G1
Melotti, G1
Soffritti, E1
Sheleketina, II1
Chiancone, FM1

Other Studies

20 other studies available for niacinamide and Hepatitis

ArticleYear
Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.
    JCI insight, 2018, 06-21, Volume: 3, Issue:12

    Topics: Animals; Chemical and Drug Induced Liver Injury; Colitis; Concanavalin A; Dextran Sulfate; Disease M

2018
Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin- nicotinamide-induced experimental diabetes mellitus.
    Free radical research, 2013, Volume: 47, Issue:10

    Topics: Animals; Antioxidants; C-Reactive Protein; Cytokines; Diabetes Mellitus, Experimental; Flavanones; H

2013
Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
    International immunopharmacology, 2015, Volume: 28, Issue:1

    Topics: Acute-Phase Reaction; Aldehyde Oxidase; Animals; Chemical and Drug Induced Liver Injury; Concanavali

2015
Sorafenib treatment during partial hepatectomy reduces tumorgenesis in an inflammation-associated liver cancer model.
    Oncotarget, 2016, Jan-26, Volume: 7, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP-Bindin

2016
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:4

    Topics: Animals; Benzenesulfonates; Collateral Circulation; Enteritis; Heme Oxygenase-1; Hepatitis; Hyperten

2009
The inactivation of cortisol in experimental diabetic animals.
    Medical journal of Osaka University, 1963, Volume: 13

    Topics: Anatomy; Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Diabetes M

1963
[Clinical study of a new compound with choleretic and liver-protective action].
    La Clinica terapeutica, 1962, Nov-15, Volume: 23

    Topics: Cholagogues and Choleretics; Cholecystectomy; Cholecystitis; Dyspepsia; Hepatitis; Humans; Liver Dis

1962
[Therapeutic trials of "Benutrex" in viral hepatitis and cirrhosis].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1962, Oct-08, Volume: 38

    Topics: Hepatitis; Hepatitis A; Humans; Liver Cirrhosis; Liver Extracts; Niacin; Niacinamide; Pantothenic Ac

1962
[CLINICO-EXPERIMENTAL STUDY OF A NEW CHOLERETIC ASSOCIATED WITH AN ANTI-SPASTIC DRUG AND WITH VITAMIN B1 AND VITAMIN PP].
    La Clinica terapeutica, 1963, Aug-31, Volume: 26

    Topics: Cholagogues and Choleretics; Cholecystitis; Cholelithiasis; Hepatitis; Jaundice; Liver Cirrhosis; Mu

1963
[RECOVERY IN 2 CASES OF HEPATIC COMA].
    Sveikatos apsauga, 1963, Volume: 8

    Topics: Adolescent; Ascorbic Acid; Cortisone; gamma-Globulins; Hepatic Encephalopathy; Hepatitis; Hepatitis

1963
[CLINICAL OBSERVATIONS ON A PHARMACOLOGICAL ASSOCIATION WITH LIPOTROPIC AND HEPATOPROTECTIVE ACTIVITY].
    Gazzetta medica italiana, 1964, Volume: 123

    Topics: Ammonium Compounds; Ascorbic Acid; Communicable Diseases; Glucuronates; Hepatitis; Hepatitis A; Huma

1964
[VITAMIN B 12 ASSOCIATED WITH FOLIC ACID, VITAMIN C AND VITAMIN PP ADMINISTERED INTRAVENOUSLY IN ACUTE VIRAL HEPATITIS].
    Minerva medica, 1965, Jul-11, Volume: 56

    Topics: Ascorbic Acid; Drug Therapy; Folic Acid; Hepatitis; Hepatitis A; Humans; Niacinamide; Vitamin B 12;

1965
[Contents of di-triphosphopyridinylnucleo tides in the blood and N'-methylnicotinamide in the urine in epidemic hepatitis].
    Sovetskaia meditsina, 1961, Volume: 25

    Topics: Coenzymes; Hepatitis; Hepatitis A; Humans; Niacinamide

1961
[The effect of riboflavin and nicotylamide on serum iron levels in pathologic states, with special reference to acute hepatitis].
    Nordisk medicin, 1951, Jan-31, Volume: 45, Issue:5

    Topics: Blood; Hepatitis; Hepatitis A; Humans; Iron; Niacin; Niacinamide; Riboflavin

1951
Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis.
    Gut, 1976, Volume: 17, Issue:2

    Topics: Adult; Aged; Ascorbic Acid Deficiency; Carotenoids; Eating; Folic Acid Deficiency; Hepatitis; Humans

1976
[Rational therapy of liver diseases in general practice].
    ZFA. Zeitschrift fur Allgemeinmedizin, 1976, Jan-20, Volume: 52, Issue:2

    Topics: Adult; Aged; Amino Acids; Chronic Disease; Drug Combinations; Fatty Liver; Female; Folic Acid; Hepat

1976
[Treatment of patients with chronic liver diseases with a hepatotrophic preparation].
    Minerva medica, 1971, Jul-21, Volume: 62, Issue:57

    Topics: Bilirubin; Cholinesterases; Chronic Disease; Folic Acid; gamma-Globulins; Hepatitis; Humans; Liver C

1971
[Clinico-experimental findings on the use of a new liver protective agent].
    Minerva medica, 1967, Apr-28, Volume: 58, Issue:34 Suppl

    Topics: Adult; Aged; Arginine; Citrulline; Female; Folic Acid; Hepatitis; Humans; Liver Cirrhosis; Male; Mid

1967
[Effect of sorbitol preparations on the vitamin saturation of the organism in patients with chronic hepatocholecystitis].
    Vrachebnoe delo, 1969, Volume: 2

    Topics: Adult; Aged; Ascorbic Acid; Avitaminosis; Cholecystitis; Chronic Disease; Citrates; Female; Hepatiti

1969
[Social aspects and new therapeutic trends in Italian vitamin research during the last 30 years].
    Acta vitaminologica et enzymologica, 1971, Volume: 25, Issue:3

    Topics: Child Health Services; Hepatitis; Humans; Italy; Liver Cirrhosis; Niacinamide; Nicotinic Acids; Orot

1971